[1]
VATTIPALLI, M. et al. 2014. Population Pharmacokinetics of Pioglitazone in South Indian Type-II Diabetic Patients. Asian Journal of Pharmaceutical and Clinical Research. 7, 4 (Sep. 2014), 102–105.